Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

FCA Draws Heavy Constitutional Fire After $1.6B J&J Verdict No Photo Available

Jeff Overley

Reeling from a record fraud verdict tied to drug promotion practices, Johnson & Johnson is pursuing a sweeping constitutional challeng... (more story)

Healthcare In Court: NIH Grant Cuts, Flo Health Trial And More No Photo Available

Gianna Ferrarin

A First Circuit panel refused to hit pause on a Massachusetts federal judge's order voiding cuts by the National Institutes of Health ... (more story)

This Week's Healthcare Earnings: J&J, Elevance, Tenet No Photo Available

Yeji Jesse Lee

Earnings season for the second quarter of the year kicked off recently with results from heavy hitters like Johnson & Johnson and Nova... (more story)